Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Case report

Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review

Authors: Chun-Yuan Lee, Yen-Hsu Chen, Po-Liang Lu

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Reactivated cytomegalovirus (CMV) infection has been known to cause significant morbidity and mortality in immunocompromised patients. However, CMV disease rarely develops in immunocompetent patients, and reported cases often present with a mild, self-limiting course, without severe life-threatening sequelae. While the colon is the most common gastrointestinal site affected by CMV disease in immunocompetent patients, rectal involvement is rarely reported. CMV proctitis can present in two distinct forms, primary and reactivated. However, reactivated CMV proctitis is rarely reported as a causative etiology of nosocomial diarrhea, except in transplant patients. Herein we present a case of reactivated CMV proctitis in an immunocompetent patient, presenting as nosocomial diarrhea. Previously reported cases of reactivated CMV proctitis in immunocompetent patients are also reviewed.

Case presentation

A 79-year-old female was admitted because of metabolic encephalopathy caused by dehydration and hypernatremia. The patient’s consciousness level returned rapidly after fluid supplementation. However, she subsequently presented with abdominal pain and diarrhea on day 8 of admission. Abdominal contrast-enhanced computed tomography on day 10 of admission demonstrated inflammation around the rectum, suggesting proctitis. Colonoscopy on day 16 of admission showed a giant ulcer at the rectum. Pathology of rectal biopsy confirmed CMV infection. The patient recovered without sequelae after 38 days of valganciclovir treatment. Follow-up colonoscopy revealed a healed ulcer over the rectum. Ten cases in the literature, plus our case, with reactivated CMV proctitis in immunocompetent patients were reviewed. We found that most patients were elderly (mean, 72 years) with a high prevalence of diabetes mellitus (54.5%). Cardinal manifestations are often non-specific (diarrhea, hematochezia, tenesmus), and eight (72.7%) developed CMV proctitis following a preceding acute, life-threatening disease, rather than as an initial presentation on admission. These manifestations frequently develop during hospitalization, and are thus often regarded as nosocomial diarrhea.

Conclusions

Clinicians should be aware of the possibility of nosocomial onset of reactivated CMV proctitis in patients hospitalized due to a preceding critical illness, although the benefits of antiviral therapy remain unclear.
Literature
1.
go back to reference Kotton CN, Kumar D, Caliendo AM, Åsberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89:779–95.CrossRefPubMed Kotton CN, Kumar D, Caliendo AM, Åsberg A, Chou S, Snydman DR, et al. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2010;89:779–95.CrossRefPubMed
2.
go back to reference Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRefPubMedPubMedCentral Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J. 2008;5:47.CrossRefPubMedPubMedCentral
3.
go back to reference Studemeister A. Cytomegalovirus proctitis: a rare and disregarded sexually transmitted disease. Sex Transm Dis. 2011;38:876–8.CrossRefPubMed Studemeister A. Cytomegalovirus proctitis: a rare and disregarded sexually transmitted disease. Sex Transm Dis. 2011;38:876–8.CrossRefPubMed
4.
go back to reference Polage CR, Solnick JV, Cohen SH. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis. 2012;55:982–9.CrossRefPubMedPubMedCentral Polage CR, Solnick JV, Cohen SH. Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis. 2012;55:982–9.CrossRefPubMedPubMedCentral
5.
go back to reference Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl. 2005;11:881–90.CrossRefPubMed Ginsburg PM, Thuluvath PJ. Diarrhea in liver transplant recipients: etiology and management. Liver Transpl. 2005;11:881–90.CrossRefPubMed
6.
7.
go back to reference Machens A, Bloechle C, Achilles E, Bause H, Izbicki J. Toxic megacolon caused by cytomegalovirus colitis in a multiply injured patient. J Trauma Acute Care Surg. 1996;40:644–6.CrossRef Machens A, Bloechle C, Achilles E, Bause H, Izbicki J. Toxic megacolon caused by cytomegalovirus colitis in a multiply injured patient. J Trauma Acute Care Surg. 1996;40:644–6.CrossRef
8.
go back to reference Lee CS, Low AH, Ender PT, Bodenheimer Jr HC. Cytomegalovirus colitis in an immunocompetent patient with amebiasis: case report and review of the literature. Mt Sinai J Med. 2004;71:347–50.PubMed Lee CS, Low AH, Ender PT, Bodenheimer Jr HC. Cytomegalovirus colitis in an immunocompetent patient with amebiasis: case report and review of the literature. Mt Sinai J Med. 2004;71:347–50.PubMed
9.
go back to reference Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13:1.CrossRef Osawa R, Singh N. Cytomegalovirus infection in critically ill patients: a systematic review. Crit Care. 2009;13:1.CrossRef
10.
go back to reference Kim CH, Bahng S, Kang KJ, Ku B-H, Jo YC, Kim JY, et al. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study. Scand J Gastroenterol. 2010;45:1295–301.CrossRefPubMed Kim CH, Bahng S, Kang KJ, Ku B-H, Jo YC, Kim JY, et al. Cytomegalovirus colitis in patients without inflammatory bowel disease: a single center study. Scand J Gastroenterol. 2010;45:1295–301.CrossRefPubMed
11.
go back to reference Cook CH. Cytomegalovirus reactivation in“immunocompetent” patients: a call for scientific prophylaxis. J Infect Dis. 2007;196:1273–5.CrossRefPubMed Cook CH. Cytomegalovirus reactivation in“immunocompetent” patients: a call for scientific prophylaxis. J Infect Dis. 2007;196:1273–5.CrossRefPubMed
12.
go back to reference Ng FH, Chau TN, Cheung TC, Kng C, Wong SY, Ng WF, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci. 1999;44:945–52.CrossRefPubMed Ng FH, Chau TN, Cheung TC, Kng C, Wong SY, Ng WF, et al. Cytomegalovirus colitis in individuals without apparent cause of immunodeficiency. Dig Dis Sci. 1999;44:945–52.CrossRefPubMed
13.
go back to reference Patra S, Samal SC, Chacko A, Mathan VI, Mathan MM. Cytomegalovirus infection of the human gastrointestinal tract. J Gastroenterol Hepatol. 1999;14:973–6.CrossRefPubMed Patra S, Samal SC, Chacko A, Mathan VI, Mathan MM. Cytomegalovirus infection of the human gastrointestinal tract. J Gastroenterol Hepatol. 1999;14:973–6.CrossRefPubMed
14.
go back to reference Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci. 2005;50:609–16.CrossRefPubMed Galiatsatos P, Shrier I, Lamoureux E, Szilagyi A. Meta-analysis of outcome of cytomegalovirus colitis in immunocompetent hosts. Dig Dis Sci. 2005;50:609–16.CrossRefPubMed
15.
go back to reference Karakozis S, Gongora E, Caceres M, Brun E, Cook JW. Life-threatening cytomegalovirus colitis in the immunocompetent patient. Dis Colon Rectum. 2001;44:1716–20.CrossRefPubMed Karakozis S, Gongora E, Caceres M, Brun E, Cook JW. Life-threatening cytomegalovirus colitis in the immunocompetent patient. Dis Colon Rectum. 2001;44:1716–20.CrossRefPubMed
16.
go back to reference Mhiri L, Kaabi B, Houimel M, Arrouji Z, Slim A. Comparison of pp 65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients. J Virol Methods. 2007;143:23–8.CrossRefPubMed Mhiri L, Kaabi B, Houimel M, Arrouji Z, Slim A. Comparison of pp 65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients. J Virol Methods. 2007;143:23–8.CrossRefPubMed
17.
go back to reference Kusne S, Grossi P, Irish W, George KS, Rinaldo C, Rakela J, et al. Cytomegalovirus pp 65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1999;68:1125–31.CrossRefPubMed Kusne S, Grossi P, Irish W, George KS, Rinaldo C, Rakela J, et al. Cytomegalovirus pp 65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation. 1999;68:1125–31.CrossRefPubMed
18.
go back to reference Bernabeu-Wittel M, Pachón-Ibáñez J, Cisneros J, Cañas E, Sánchez M, Gómez MA, et al. Quantitative pp 65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients. J Infect. 2005;51:188–94.CrossRefPubMed Bernabeu-Wittel M, Pachón-Ibáñez J, Cisneros J, Cañas E, Sánchez M, Gómez MA, et al. Quantitative pp 65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients. J Infect. 2005;51:188–94.CrossRefPubMed
19.
go back to reference Vaziri S, Pezhman Z, Sayyad B, Mansouri F, Janbakhsh A, Afsharian M, et al. Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: a meta-analysis. J Res Med Sci. 2014;19:1185–92.PubMedPubMedCentral Vaziri S, Pezhman Z, Sayyad B, Mansouri F, Janbakhsh A, Afsharian M, et al. Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: a meta-analysis. J Res Med Sci. 2014;19:1185–92.PubMedPubMedCentral
20.
go back to reference Maffini E, Giaccone L, Festuccia M, Brunello L, Busca A, Bruno B. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Rev. Hematol. 2016:1–12. Maffini E, Giaccone L, Festuccia M, Brunello L, Busca A, Bruno B. Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation. Expert Rev. Hematol. 2016:1–12.
21.
go back to reference Alam I, Shanoon D, Alhamdani A, Boyd A, Griffiths A, Baxter JN. Severe proctitis, perforation, and fatal rectal bleeding secondary to cytomegalovirus in an immunocompetent patient: report of a case. Surg Today. 2007;37:66–9.CrossRefPubMed Alam I, Shanoon D, Alhamdani A, Boyd A, Griffiths A, Baxter JN. Severe proctitis, perforation, and fatal rectal bleeding secondary to cytomegalovirus in an immunocompetent patient: report of a case. Surg Today. 2007;37:66–9.CrossRefPubMed
22.
go back to reference Yuko A, Takeshi K, Eriko M, Yoshinori D, Yoko M, Masaru O, et al. A case of cytomegalovirus proctitis associated with both rectovaginal and rectovesical fistulae. Gastroenter Endosc. 2006;48:1577–84. Yuko A, Takeshi K, Eriko M, Yoshinori D, Yoko M, Masaru O, et al. A case of cytomegalovirus proctitis associated with both rectovaginal and rectovesical fistulae. Gastroenter Endosc. 2006;48:1577–84.
23.
24.
go back to reference Wong JM, Huang SH, Chen JC, Wang CY, Wang TH. Cytomegalovirus proctitis: report of clinical, endoscopic and pathologic features in a patient without evidence of immunodeficiency. Chinese J Gastroenterol. 1988;5(2):119–23. Wong JM, Huang SH, Chen JC, Wang CY, Wang TH. Cytomegalovirus proctitis: report of clinical, endoscopic and pathologic features in a patient without evidence of immunodeficiency. Chinese J Gastroenterol. 1988;5(2):119–23.
Metadata
Title
Reactivated cytomegalovirus proctitis in an immunocompetent patient presenting as nosocomial diarrhea: a case report and literature review
Authors
Chun-Yuan Lee
Yen-Hsu Chen
Po-Liang Lu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2218-y

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.